pennsylvania-biotech
(2)Legend
Company
Founder · Executive · Scientist
Nicholas Nicolaides Keeps Returning to the Same Tiny Question: What Is the Antibody Missing?
He turned a lesson in genetic error correction into one biotech company, stayed after its $325 million sale, then began again with old collaborators and a new puzzle: why good antibodies sometimes go quiet.
nicholas-nicolaides · navrogenRead →
Health
The Cancer Drug Isn’t Broken. Navrogen Thinks the Tumor Is Blocking the Signal
A tiny Pennsylvania biotech is betting that some antibody therapies fail for a surprisingly fixable reason: tumors throw molecular sand in the gears. Its answer is to redesign the antibody - or remove the sand.
biotechnology · cancer-therapyRead →